131 related articles for article (PubMed ID: 25868956)
1. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
3. Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Yokohama A; Tsukamoto N; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Nojima Y
Ann Hematol; 2004 Feb; 83(2):120-3. PubMed ID: 14513289
[TBL] [Abstract][Full Text] [Related]
4. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
5. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
Yamao H; Kondo E; Miura A; Mizuno H; Yuge M
Rinsho Ketsueki; 1998 Nov; 39(11):1121-6. PubMed ID: 9866425
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
9. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
10. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
Cohen Y; Amir G; Rachmilewitz EA; Polliack A
Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488
[No Abstract] [Full Text] [Related]
11. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation.
Grigg AP; Seymour JF
Leuk Lymphoma; 2002 Apr; 43(4):889-92. PubMed ID: 12153181
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
15. Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma.
Okur FV; Oguz A; Karadeniz C; Citak C; Poyraz A; Boyunaga O
Pediatr Hematol Oncol; 2006; 23(1):25-31. PubMed ID: 16326409
[TBL] [Abstract][Full Text] [Related]
16. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
17. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Griffin TC; Weitzman S; Weinstein H; Chang M; Cairo M; Hutchison R; Shiramizu B; Wiley J; Woods D; Barnich M; Gross TG;
Pediatr Blood Cancer; 2009 Feb; 52(2):177-81. PubMed ID: 18816698
[TBL] [Abstract][Full Text] [Related]
18. Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand.
Suvatte V; Issaragrisil S; Chandanayingyong D; Mahasandana C; Tanphaichitr VS; Jirapinyo P
J Med Assoc Thai; 1990 Oct; 73(10):572-80. PubMed ID: 2280205
[TBL] [Abstract][Full Text] [Related]
19. Primary Burkitt's lymphoma only involving the chest wall at relapse in a child.
Yaris N; Cakir M; Ahmetoglu A; Ersoz S
Leuk Lymphoma; 2004 Apr; 45(4):837-9. PubMed ID: 15160968
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
